An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers
Status:
Completed
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
This study aims to investigate whether FABALOFEN 60 is bioequivalent to JAPROLOX® TABLETS
after a single oral administration of each loxoprofen formulation in healthy subjects by
assessing of pharmacokinetic properties including AUC, Tmax and Cmax and to evaluate the
safety of test drug FABALOFEN 60 and reference drug JAPROLOX® TABLETS during drug
administration.
Phase:
Phase 1
Details
Lead Sponsor:
Centre of Clinical Pharmacology, Hanoi Medical University